BCL-2 drugs for Acute Myeloid Leukemia
8 tracked BCL-2 drugs in the Acute Myeloid Leukemia race. The class explanation lives on the BCL-2 page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.
1 approved / phase 42 Phase 31 Phase 21 Phase 1/22 Phase 11 preclinical / unstaged
Head-to-head evidence: FCN-338 vs Venetoclax · FXS0683 vs Venetoclax · Lisaftoclax vs Venetoclax · Lonitoclax vs Venetoclax · Mesutoclax vs Venetoclax · Sonrotoclax vs Venetoclax